Downright delirious diabetic debacle: Fake tweet leads to $35 insulin cap
On Mar. 1, Eli Lilly, also known as Lilly, a pharmaceutical company that prides itself on “integrity, excellence and respect for people,” announced that they will be capping their insulin products at $35 for a one month’s supply of the life-saving medication. The change seeks…